PROPESS

This brand name is authorized in Austria, Brazil, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, Romania, South Africa, Spain, Turkey, UK.

Active ingredients

The drug PROPESS contains one active pharmaceutical ingredient (API):

1	Dinoprostone UNII K7Q1JQR04M - DINOPROSTONE
	Read more about Dinoprostone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G02AD02	Dinoprostone	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02A Oxytocics → G02AD Prostaglandins
Discover more medicines within G02AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	521401401175312
EE	Ravimiamet	1759080
ES	Centro de información online de medicamentos de la AEMPS	62088
FI	Lääkealan turvallisuus- ja kehittämiskeskus	082727
FR	Base de données publique des médicaments	60297517
GB	Medicines & Healthcare Products Regulatory Agency	104966
HK	Department of Health Drug Office	41119
HR	Agencija za lijekove i medicinske proizvode	HR-H-724681688
IL	מִשְׂרַד הַבְּרִיאוּת	6873
JP	医薬品医療機器総合機構	24997A2H1020
LT	Valstybinė vaistų kontrolės tarnyba	1085995
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	432M96
NL	Z-Index G-Standaard, PRK	50970
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65241001
TR	İlaç ve Tıbbi Cihaz Kurumu	8697621900530
ZA	Health Products Regulatory Authority	33/19/0059